Maricel Apuli sold $146K of BridgeBio Pharma stock
By AlphaYouPublished Form 4
Apuli Maricel
Reporting filer
Maricel Apuli reported selling 2,000 shares of BridgeBio Pharma, Inc. for about $146K ($72.85 a share on average). Form 4 filed Nov 3, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 3, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Apuli Maricel | 2026-10-30 | S | Sale | 2000 | 72.85 | 120,687 | 4 days | Filed terms
|
Common Stock
- Owner
- Apuli Maricel
- Date
- 2026-10-30
- Code
- S
- Action
- Sale
- Quantity
- 2000
- Price
- 72.85
- Following holdings
- 120,687
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-30
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2000
- transaction Price Per Share: 72.85
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 120687
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Apuli Maricel: Chief Accounting Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on September 8, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.